If you are seeing this text you need to turn on Javascript or upgrade your Version of Flash

Why Advertise in BioSupply Trends Quarterly?

January 2010 Plasma
  • IVIG Reimbursement Challenges for Physicians
  • Outlook on Emerging IVIG Treatment Options
  • Standards and Protocols for IVIG Treatment
  • IG Infusion Environments: Comparing Costs, Safety and Privacy
  • Diagnosis and Treatment of Cancer
  • Update on Acquired Hemophilia
  • Myths and Facts: Stroke
April 2010 Safety
  • Causes and Problems of Drug Shortages
  • Top Counterfeit Drugs
  • Safety in the Healthcare Workplace
  • Proactive Screening for Women's Health
  • Lifelong Need for Immune Globulin: Weighing the Pros and Cons
  • Myths and Facts: Heart Disease
July 2009 Vaccines
  • New Vaccine Technology
  • Flu Season: A Historical Comparison
  • Vaccines on the Horizon
  • Understanding and Treating Immune Globulin Side Effects
  • Update on Meningitis
  • Myths and Facts: Lyme Disease
October 2009 Innovation
  • Combining Alternative and Mainstream Treatments
  • New Drugs to Treat Autoimmune Diseases
  • Specialty Tests for Chronic Disease
  • Immune Globulin: Emerging Research on Dosing Strategies
  • Update on Aging
  • Myths and Facts: Asthma
In Every Issue!
  • Washington Report
    Healthcare legislation and policy updates
  • Patient Profile
    Real-life experiences
  • Leadership Corner
    Executives helping healthcare care
  • Industry Insight
    The future of biopharmaceutical products and practices
  • BioResources
    Cutting-edge research, updates and informative websites
  • BioDashboard
    Product availability and reimbursement rates
  • Product Catalog
    Directory of plasma products, vaccines and other specialty pharmaceuticals expertly managed through FFF Enterprises' secure distribution channel

For Ad Specifications please download our Media Kit below:
Download Media Kit
About | Subscribe | Advertise | Download Media Kit | Contact Us

FFF Enterprises.com | Privacy | Terms of Use | Site Map | © 2011 FFF Enterprises, Inc.